Page 8 - From Bench News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from From bench. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In From Bench Today - Breaking & Trending Today

Investment breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns


Investment breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns
Media
Links
Dr. Metin Colpan, founder of Nasdaq listed Qiagen N.V. acquired 5% of BrainRepair UG shares worth EUR 15M
One of the most successful inventors and entrepreneurs who masterminded the unprecedented success of Qiagen N.V. from a start-up to a 10 billion market cap enterprise has taken the decision to refocus his activities on BrainRepair UG, a spin-off of the Ruhr-University Bochum (RUB). BrainRepair UG has developed a unique method based on own (autologous) cord blood stem cells to treat brain damage and cerebral palsy (CP) in newborns affecting 70,000 babies in the EU each year. Metin Colpan’s patented invention has become a standard method recommended by the World Health Organization (WHO) and is used by researchers all over the world, changing the way they can access, purify and understand genetic data in DNA and RNA. The European Patent Office states “…The tire ....

Nordrhein Westfalen , Thierry Bernard , Metin Colpan , Arne Jensen , European Patent Office , World Health Organization , European Commission , European Medicines Agency , Frankfurt Stock Exchange , University Bochum , Ruhr University Bochum , Advisory Board , Nasdaq First North , Orphan Drug Designation , European Medicines , Prime Standard , Chief Executive , Orphan Medicinal Product Designation , European Inventor Award , Cord Blood Therapy , Infantile Cerebral Palsy , From Bench , Obstet Gynecol Int , Autologous Cord Blood Therapy , Pediatric Ischemic Stroke , Cerebral Palsy Caused ,